Q2 2026 Thermo Fisher Scientific Inc Earnings Call Transcript
Key Points
- Thermo Fisher Scientific Inc (TMO) reported a 10% increase in revenue to $11.99 billion for the second quarter.
- Adjusted operating income grew by 15% to $2.73 billion, with an operating margin expansion of 90 basis points to 22.8%.
- The company launched several new technologies, including next-generation Orbitrap platforms and AI-driven capabilities, enhancing their industry leadership.
- Thermo Fisher Scientific Inc (TMO) raised its full-year revenue guidance to a range of $47.4 billion to $48.1 billion, reflecting strong operational performance.
- The company successfully executed strategic acquisitions, such as Clareo, which are performing well and contributing to revenue and earnings growth.
- The academic and government market showed only low single-digit growth, indicating a stabilization period rather than robust recovery.
- The divestiture of the microbiology business is expected to reduce 2026 revenue by approximately $200 million and adjusted EPS by $0.05.
- Foreign exchange rates posed a $100 million lower revenue tailwind than previously expected.
- Despite growth in China, the academic and government sectors remain muted, not contributing significantly to overall growth.
- The company's leverage ratio remains relatively high at 3.6 times gross debt to adjusted EBITDA.
Good morning, ladies and gentlemen, and welcome to the Thermo Fisher Scientific 2026 Second Quarter Conference Call.
After today's prepared remarks, we will host a question-and-answer session. If you would like to ask a question, please press *1 to raise your hand. To withdraw your question, press *1 again. I would like to introduce our moderator for the call, Mr. Rafael Tejada, Vice President, Investor Relations. Mr. Tejada, you may begin the call.
Good morning, and thank you for joining us.
On the call with me today is Mark Casper, our Chairman and Chief Executive Officer and Jim Meyer, Senior Vice President and Chief Financial Officer.
Please note this call is being webcast live. And will be archived on the Investors section of our website, thermofisher.com, under the heading News, Events and Presentations until October 20, 2026.
A copy of the press release of our second quarter earnings is available in the Investors section of our website
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
